Drug General Information
Drug ID
D04DQF
Former ID
DNC007236
Drug Name
2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528738]
Structure
Download
2D MOL

3D MOL

Formula
C17H17NO4
Canonical SMILES
CC(=O)C1=CC=CC(=C1)C2=CC(=O)C=C(O2)N3CCOCC3
InChI
1S/C17H17NO4/c1-12(19)13-3-2-4-14(9-13)16-10-15(20)11-17(22-16)18-5-7-21-8-6-18/h2-4,9-11H,5-8H2,1H3
InChIKey
MUGFHNCVHGYLEQ-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) DNA-dependent protein kinase catalytic subunit Target Info Inhibitor [528738]
KEGG Pathway Non-homologous end-joining
Cell cycle
NetPath Pathway IL1 Signaling Pathway
Pathway Interaction Database DNA-PK pathway in nonhomologous end joining
Coregulation of Androgen receptor activity
Class I PI3K signaling events mediated by Akt
BARD1 signaling events
Reactome Nonhomologous End-Joining (NHEJ)
WikiPathways DNA Damage Response
Non-homologous end joining
FAS pathway and Stress induction of HSP regulation
Cytosolic sensors of pathogen-associated DNA
Retinoblastoma (RB) in Cancer
Prostate Cancer
Double-Strand Break Repair
Cell Cycle
miRNA Regulation of DNA Damage Response
References
Ref 528738J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
Ref 528738J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.